Ampullary Carcinoma Clinical Trial
Official title:
Efficacy and Safety of Surufatinib Combined With Toripalimab and AG Regiments for First-line Treatment of Unresectable or Relapsing Metastatic Ampullary Carcinoma
A Phase Ⅱ, single-arm study to assess the safety, tolerability, and efficacy of Surufatinib Combination With Toripalimab in Patients With recurrent or metastatic ampulla tumors.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00753675 -
Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer
|
Phase 2 | |
Completed |
NCT01844245 -
Endobiliary RFA for Unresectable Malignant Biliary Strictures
|
N/A | |
Recruiting |
NCT02238613 -
Radioactive Stents for Treatment of Unresectable Biliary Tract Cancer
|
N/A |